AMCA
WST icon

Arthur M. Cohen & Associates’s West Pharmaceutical WST Stock Holding History

Arthur M. Cohen & Associates’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-650
Closed -$213K – 139
2024
Q4 		$213K Sell
650
-130
-17% -$40.9K 0.04% 132
2024
Q3 		$234K Hold
780
– – 0.04% 126
2024
Q2 		$257K Buy
780
+30
+4% +$10.6K 0.05% 121
2024
Q1 		$297K Buy
+750
New +$277K 0.06% 108

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Arthur M. Cohen & Associates's WST Position: Q1 2025 in Review

Arthur M. Cohen & Associates sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 650 shares — an estimated $213K sold.

Arthur M. Cohen & Associates first reported a position in WST in Q1 2024 and held it in 4 quarters. The position peaked at $297K in Q1 2024. 715 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Arthur M. Cohen & Associates reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Arthur M. Cohen & Associates sold 650 West Pharmaceutical shares in Q1 2025, an estimated $213K.
  • Arthur M. Cohen & Associates first reported a position in West Pharmaceutical in Q1 2024 and held it in 4 quarters.
  • Arthur M. Cohen & Associates's West Pharmaceutical position peaked at $297K in Q1 2024.
  • 715 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Arthur M. Cohen & Associates's 13F filing for Q1 2025, filed 10 Apr 2025.